更正：Iterum Therapeutics第2季度EPS $（0.13）未达到$（0.11）估计值。现金和等价物1300万美元，跑道进入2026年

Iterum Therapeutics (NASDAQ: ITRM) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 43.48 percent increase over losses of $(0.23) per share from the same period last year.